Call for Your FREE Evaluation (877) 503-1595

Pharmaceutical and Medical Device News

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

Pharmaceutical and Medical Device News

MENINGITIS OUTBREAK HASN’T ENDED

The fungal meningitis outbreak that resulted from a tainted steroid injection this fall is not over.  Several months later, there have been over 23 new cases of spinal abscesses attributable to the steroid injection manufactured by New England Compounding Pharmacy. Luckily the new wave of cases has involved spinal abscesses, and have not yet developed…..

Posted in Pharmaceutical and Medical Device News,
Tagged fungal meningitis, meningitis,

PRADAXA VS. WARFARIN: BETTER OR JUST MORE COSTLY?

Is Pradaxa, the first alternative to the original blood thinner warfarin, worth its $3000 a year price tag, or is it just as risky as the $200 a year warfarin?  The number of Pradaxa injuries leading to lawsuits would indicate that the new drug isn’t a step forward for patients at all. The FDA approved…..

Posted in Pharmaceutical and Medical Device News,
Tagged Blood Thinning Medication, Pradaxa,

GENERIC FORM OF ANTIDEPRESSANT WELLBUTRIN PULLED OFF THE MARKET

The FDA has asked Teva Pharmaceuticals to stop shipping Budeprion XL 300, the generic alternative to the popular antidepressant Wellbutrin XL 300.  Consumers have been complaining that the drug has not been effective, and that they have been suffering side effect such as anxiety, headaches, and insomnia.  After testing, the FDA found that the generic…..

Posted in Pharmaceutical and Medical Device News,
Tagged Antidepressant, Birth Defects, Wellbutrin,

STEROID INJECTIONS CAUSE MENINGITIS OUTBREAK

A fairly standard steroid injection used to treat back pain has resulted in a meningitis outbreak in five states: Tennessee, Virginia, Maryland, Florida, and North Carolina.  It has led to 26 people thus far getting sick, including 4 for whom it was fatal.  The drug was made by a pharmacy in Massachusetts called New England…..

Posted in Pharmaceutical and Medical Device News,
Tagged CDC, fungal meningitis, malpractice, meningitis, steroid injections,

LATEST DEVELOPMENTS IN RISPERDAL LITIGATION

Today Johnson & Johnson settled five of its lawsuits claiming that its antipsychotic drug Risperdal caused boys to grow breast tissue.  The hearing took place in Philadelphia, but the terms of the settlements were not disclosed. The settlement of these cases comes on the heels of J&J’s efforts to keep former FDA chief David Kessler…..

Posted in Pharmaceutical and Medical Device News,
Tagged J and J, johnson and johnson, risperdal, risperdal litigation,

SETTLEMENT NEWS ON DEPUY HIP IMPLANTS

On September 12, 2012, it was announced that the first cases in the DePuy Hip Implant Recall are to be settled for $200,000 each, disappointing and outraging clients who were expecting a much higher settlement amount.  Many experts were estimating the cases to be worth more than $500,000.

Posted in Pharmaceutical and Medical Device News,
Tagged DePuy Hip Implant Recall, depuy hip implants,

UPDATE ON MENINGITIS OUTBREAK

There are new figures on the recent fungal meningitis outbreak that resulted from tainted steroid shots.  Now it is believed that 13,000 people received the shot, though not all the shots were given in the back.  The number of confirmed cases has now reached 105, with eight fatalities. These growing numbers are causing renewed attention…..

Posted in Pharmaceutical and Medical Device News,
Tagged meningitis, FDA, Meningitis Outbreak, New England Compounding Center,

PSYCHIATRIST TRIES TO BRING UNETHICAL PRACTICES TO LIGHT

On Thursday October 4, controversial British psychiatrist David Healy spoke at the American Psychiatric Associations annual meeting about conflicts of interest between psychiatrists and the drug industry.  This is a topic that is very close to our hearts at Kirkendall Dwyer, where our attorneys are committed to fighting xxxx.

Posted in Pharmaceutical and Medical Device News,
Tagged APA, David Healy, Psychiatry Malpractice,

DALLAS COMPOUNDING PHARMACY ACCUSED OF CAUSING DEATHS

With compounding pharmacies coming under scrutiny as a result of the recent meningitis outbreak, a Dallas compounding pharmacy whose mislabeled medications caused the deaths of three people in Washington State is coming to light.  The pharmacy, called ApotheCure, mixed an injectable painkiller that was 640% stronger than prescribed.

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Meningitis Outbreak, ApotheCure, Injectable Painkiller,

JOHNSON & JOHNSON TRIES TO ADDRESS CRITICAL DRUG SHORTAGE

Since 2010, ovarian cancer patients have been missing an effective and palatable chemotherapy drug called Doxil.  In 2010, FDA inspectors came upon contamination problems at the Ohio plant, and since then the drug has been in severe shortage.  About 7000 patients a year have used this drug, but by November of 2010, the only factory…..

Posted in Pharmaceutical and Medical Device News,
Tagged FDA, Doxil, J & J, Johnson & Johnson, Overian Cancer,